Infectious or Allergic Chronic Laryngitis Follow-up

  • Author: Stefano Berliti, MD, FACP; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Aug 11, 2011
 

Further Inpatient Care

  • Hospital admission is necessary when signs and symptoms of toxemia exist and intravenous antibiotic therapy is needed (eg, severe bacterial or fungal infections).
  • ICU monitoring may be required when stridor or any other symptom suggesting important involvement of the airways exists. This may occur in the late stages of diseases, such as Wegener granulomatosis, rheumatoid arthritis, relapsing polychondritis, or amyloidosis, or with conditions that severely compromise the structure and functions of the larynx. Airway monitoring becomes of paramount importance.
  • When a risk of aspiration exists, alternative forms of feeding may be used until the risk subsides.
  • When contagious diseases are suspected, the appropriate isolation procedures must be implemented before identification of the responsible organisms and initiation of the indicated medical treatment.
  • Further inpatient care is required for all cases in which verification of the response to the therapy and its optimization prior to discharge are needed.
  • If chronic laryngitis is part of a systemic disease, then the treatment plan must take into account the different necessities that vary from case to case.
Next

Further Outpatient Care

  • Further outpatient care is indicated whenever adherence to therapy may not be optimal and verification is believed to be necessary.
  • Further outpatient care is indicated when prophylactic and epidemiological recommendations must be reinforced (eg, abstinence from cigarette smoking, airborne isolation and medical treatments for household contacts of a patient with tuberculosis).
  • Further outpatient care is indicated when the physician wants to ensure that the pathologic findings of the larynx are regressing according to treatment plan expectations.
Previous
Next

Transfer

Transfer may be problematic only when respiration is compromised and risk of acute insufficiency exists. In these circumstances, preventive measures must be undertaken, and appropriate surgical instrumentation to perform a tracheostomy should be available.

Previous
Next

Complications

  • The most difficult problems that occur in patients with chronic laryngitis are as follows:
    • Systemic spread or spread to the surrounding structures of the eventual infectious process
    • Laryngeal stenosis due to acute suprainfection of a chronic situation and consequent edema or stenosis secondary to a long-term process that has not been addressed
    • Vocal cords with excessive reactive growth and permanent damage to their structure and, consequently, to their function
    • Transformation into cancer
Previous
Next

Prognosis

  • Prognosis mainly relates to the causative process.
Previous
Next

Patient Education

  • Detailed information regarding occupational/environmental substances and/or habits that might have caused a patient's chronic laryngitis must be provided. Strategies to avoid the causative factors and their consequences must be taught.
  • Avoidance of cigarette smoking and secondhand smoke are of paramount importance.
  • A speech therapist must be consulted when voice rehabilitation is needed. Recommend appropriate use of the voice.
  • Educate patients regarding appropriate handling of medications. Inhaled corticosteroids may cause chronic laryngitis, presumably because of the local immunosuppressive effect, thus causing oral candidiasis. Inhaled corticosteroids can cause dysphonia, probably secondary to a myopathic effect. These effects can be minimized through dose reduction, switching to twice-daily administration, mouth rinsing, and the use of a spacer device.
  • Patients should be aware that obesity is a risk factor for the development of GERD, probably related to increased intra-abdominal pressure.
  • For excellent patient education resources, visit eMedicine's Ear, Nose, and Throat Center. Also, see eMedicine's patient education article Laryngitis.
Previous
 
Contributor Information and Disclosures
Author

Stefano Berliti, MD, FACP  Physician, Department of Medicine - Geriatrics, Kent and Canterbury Hospital, East Kent Hospitals University Trust, UK

Stefano Berliti, MD, FACP is a member of the following medical societies: American College of Physicians

Disclosure: Nothing to disclose.

Coauthor(s)

Michael Omidi, MD  Staff Physician, Department of Surgery, Northwestern University Memorial Hospital

Disclosure: Nothing to disclose.

Barry L Wenig, MD, MPH, FACS  Professor, Department of Otolaryngology-Head and Neck Surgery, Feinberg School of Medicine, Northwestern University; Chief, Division of Otolaryngology-Head and Neck Surgery, Evanston Northwestern Healthcare

Barry L Wenig, MD, MPH, FACS is a member of the following medical societies: Academy of Medicine of New Jersey, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Association, American Laryngological Rhinological and Otological Society, American Medical Association, American Rhinologic Society, American Society for Head and Neck Surgery, American Society for Laser Medicine and Surgery, Association for Research in Otolaryngology, Chicago Medical Society, New York Academy of Medicine, New York Academy of Sciences, New York Head and Neck Society, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

John M Truelson, MD, FACS  Chairman, Division of Head and Neck Surgery, Associate Professor, Department of Otorhinolaryngology, University of Texas Southwestern Medical Center at Dallas

John M Truelson, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Society for Head and Neck Surgery, Phi Beta Kappa, and Texas Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Robert M Kellman, MD  Professor and Chair, Department of Otolaryngology and Communication Sciences, State University of New York Upstate Medical University

Robert M Kellman, MD is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Rhinologic Society, American Society for Head and Neck Surgery, Medical Society of the State of New York, and Triological Society

Disclosure: GE Healthcare Honoraria Review panel membership; Revent Medical Honoraria Review panel membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

References
  1. Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol. Mar 2006;101(3):470-8. [Medline].

  2. Fuchs M, Bücheler M. [Chronic hyperplastic laryngitis following treatment of hypertension with angiotensin converting enzyme-inhibitor]. HNO. Nov 2004;52(11):998-1000. [Medline].

  3. Kania RE, Hartl DM, Badoual C, Le Maignan C, Brasnu DF. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx. Head Neck. Mar 2005;27(3):258-62. [Medline].

  4. Akhavan A, Ajalloueyan M, Ghanei M, Moharamzad Y. Late laryngeal findings in sulfur mustard poisoning. Clin. Toxicol (Phila). Feb. 2009;47(2):142-4. [Medline].

  5. Hiraga A, Kamitsukasa I, Araki N, Yamamoto H. Hoarseness in pellagra. J Clin Neurosci. Jun 2011;18(6):870-1. [Medline].

  6. Oz F, Kalekoglu N, Karakullukçu B, Oztürk O, Oz B. Lipoid proteinosis of the larynx. J Laryngol Otol. Sep 2002;116(9):736-9. [Medline].

  7. Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. February 2006;116 (2):254-60. [Medline].

  8. Bluestone, Stool, Kenna. Pediatric Otolaryngology. Vol 2. Philadelphia:. WB Saunders Co;1996:1144-52, 1253-9.

  9. Cummings CW. Otolaryngology Head and Neck Surgery. 3rd ed. St. Louis:. Mosby-Year Book;1998:1985-1992.

  10. Ebenfelt A, Finizia C. Absence of bacterial infection in the mucosal secretion in chronic laryngitis. Laryngoscope. Nov 2000;110(11):1954-6. [Medline].

  11. Fu YS, Wenig BM, Abemayor E, Wenig BL. Head and Neck Pathology. Philadelphia:. Churchill Livingstone;2001:319-323.

  12. Hanson DG, Jiang JJ. Diagnosis and management of chronic laryngitis associated with reflux. Am J Med. Mar 6 2000;108 Suppl 4a:112S-119S. [Medline].

  13. Lee KJ. Essential Otolaryngology-Head and Neck Surgery. 7th ed. Appleton & Lange;1998:830-838.

  14. Paparella MM. Otolaryngology. 3rd ed. Philadelphia:. WB Saunders Co;1991:2247-2253.

Previous
Next
 
Illustration of the larynx.
Illustration of the glottic and supraglottic larynx.
Illustration of the larynx, posterior view.
Illustration of the larynx, nasopharyngeal view.
Illustration of the intrinsic muscles of the larynx, sagittal view.
Illustration of the intrinsic muscles of the larynx, sagittal view.
Illustration of the extrinsic muscle insertions of the larynx.
Illustration of the intrinsic muscles of the larynx, superior view.
Illustration of the intrinsic muscles of the larynx.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.